Rhabdomyolysis as a manifestation of clomipramine poisoning
Keywords:
Clomipramine, Antidepressive agents, tricyclic, Rhabdomyolysis, Poisoning, ToxicologyAbstract
CONTEXT: Tricyclic antidepressive agents are widely used in suicide attempts and present a variety of deleterious effects. Rhabdomyolysis is a rare complication of such poisoning. CASE REPORT: A 55-year-old woman ingested 120 pills of 25 mg clomipramine in a suicide attempt two days before admission. After gastric lavage in another emergency department on the day of intake, 80 pills were removed. On admission to our department, she was disoriented, complaining of a dry mouth and tremors at the extremities. An electrocardiogram showed a sinus rhythm with narrow QRS complexes. Laboratory results showed high creatine phosphokinase (CK = 15,094 U/l on admission; normal range = 26 to 140 U/l), hypocalcemia, slightly increased serum transaminases and mild metabolic acidosis. The patient’s medical history included depression with previous suicide attempts, obsessive-compulsive disorder, hypothyroidism and osteoporosis. She presented cardiac arrest with pulseless electric activity for seven minutes and afterwards, without sedation, showed continuous side-to-side eye movement. She developed refractory hypotension, with need for vasopressors. Ceftriaxone and clindamycin administration was started because of a hypothesis of bronchoaspiration. The patient remained unresponsive even without sedation, with continuous side-to-side eye movement and a decerebrate posture. She died two months later. Rhabdomyolysis is a very rare complication of poisoning due to tricyclic drugs. It had only previously been described after an overdose of cyclobenzaprine, which has a toxicity profile similar to tricyclic drugs. CONCLUSIONS: Although arrhythmia is the most important complication, rhabdomyolysis should be investigated in cases of clomipramine poisoning.
Downloads
References
Buckley NA, Whyte IM, Dawson AH, McManus PR, Ferguson NW. Self- poisoning in Newcastle, 1987-1992. Med J Aust. 1995;162(4):190-3.
Obafunwa JO, Busuttil A. Deaths from substance overdose in the Lothian and Borders region of Scotland (1983-1991). Hum Exp Toxicol. 1994;13(6):401-6.
Coleridge J, Cameron PA, Drummer OH, McNeil JJ. Survey of drug- related deaths in Victoria. Med J Aust. 1992;157(7):459-62.
Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ. 1995;310(6974):215-8.
Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ. 1995;310(6974):221-4.
Kerr GW, McGuffie AC, Wilkie S. Tricyclic antidepressant overdose: a review. Emerg Med J. 2001;18(4):236-41.
Crome P, Newman B. Fatal tricyclic antidepressant poisoning. J R Soc Med. 1979;72(9):649-53.
Henry JA. A fatal toxicity index for antidepressant poisoning. Acta Psychiatr Scand Suppl. 1989;354:37-45.
Farmer RD, Pinder RM. Why do fatal overdose rates vary between antidepressants? Acta Psychiatr Scand Suppl. 1989;354:25-35.
Bramble MG, Lishman AH, Purdon J, Diffey BL, Hall RJ. An analysis of plasma levels and 24-hour ECG recordings in tricyclic antidepressant poisoning: implications for management. Q J Med. 1985;56(219):357-66.
Roberge RJ, Martin TG, Hodgman M, Benitez JG. Acute chemical pancreatitis associated with a tricyclic antidepressant (clomipramine) overdose. J Toxicol Clin Toxicol. 1994;32(4):425-9.
Kulig W, Bar-Or D, Cantrill SV, Rosen P, Rumack BH. Management of acutely poisoned patients without gastric emptying. Ann EmergMed. 1985;14(6):562-7.
Bosse GM, Barefoot JA, Pfeifer MP, Rodgers GC. Comparison of three methods of gut decontamination in tricyclic antidepressant overdose. J Emerg Med. 1995;13(2):203-9.
Thorstrand C. Clinical features in poisonings by tricyclic antidepressants with special reference to the ECG. Acta Med Scand. 1976;199(5):337-44.
Hultén BA, Heath A. Clinical aspects of tricyclic antidepressant poisoning. Acta Med Scand. 1983;213(4):275-8.
Boehnert MT, Lovejoy FH Jr. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med. 1985;313(8):474-9.
Marshall JB. Tricyclic overdose. JAMA. 1980;244(17):1900.
Dale O, Hole A. Biphasic time-course of serum concentrations of clomipramine and desmethylclomipramine after a near-fatal overdose. Vet Hum Toxicol. 1994;36(4):309-10.
Masters AB. Delayed death in imipramine poisoning. Br Med J. 1967;3(5569):866-7.
McAlpine SB, Calabro JJ, Robinson MD, Burkle FM Jr. Late death in tricyclic antidepressant overdose revisited. Ann Emerg Med. 1986;15(11):1349-52.
Stevens E, Roman A, Houa M, Razavi D, Jaspar N. Severe hyperthermia during tetrabenazine therapy for tardive dyskinesia. Intensive Care Med. 1998;24(4):369-71.
Chabria SB. Rhabdomyolysis: a manifestation of cyclobenzaprine toxicity. J Occup Med Toxicol. 2006;1:16.
O’Riordan W, Gillete P, Calderon J, Stennes RL. Overdose of cyclobenzaprine, the tricyclic muscle relaxant. Ann Emerg Med. 1986,15(5):592-3.
François B, Marquet P, Desachy A, et al. Serotonin syndrome due to an overdose of moclobemide and clomipramine. A potentially life- threatening association. Intensive Care Med. 1997;23(1):122-4.
Ferrer-Dufol A, Perez-Aradros C, Murillo EC, Marques-Alamo JM. Fatal serotonin syndrome caused by moclobemide-clomipramine overdose. J Toxicol Clin Toxicol. 1998;36(1-2):31-2.